USFDA completes GMP inspection at Dr. Reddy's API Middleburgh facility in New York

17 May 2025 Evaluate

United States Food & Drug Administration (USFDA) has completed a GMP inspection at Dr. Reddy’s Laboratories’ API Middleburgh facility in New York. The inspection was conducted from May 12, 2025 to May 16, 2025. The company has been issued a Form 483 with two observations, which it will address within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1253.60 -17.45 (-1.37%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×